James Engelhart - Chief Financial Officer, Biohaven Pharmaceutical Holding Co Ltd

As of January 8, 2021


James Engelhart Net Worth

  • Net worth is estimated to be at least $6.83M
  • Owns at least 4,522 units of Biohaven Pharmaceutical Holding Co Ltd stock
  • Sold an estimated value of $6.57M in the last 4 years at Biohaven Pharmaceutical Holding Co Ltd

James Engelhart Trading

  • Largest purchase of shares was 73,725 units , worth over $440.76K on June 12, 2020
  • Largest sale of shares was 73,725 units , worth over $4.87M on June 12, 2020
  • In total has made about 12 transactions over 4 years
  • Usually trades in May, with the busiest year in 2018 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James Engelhart Mailing Address

  • Mailing address is C/o Biohaven Pharmaceutical Holding Comp 234 Church Street New Haven CT 06510 CT

Biohaven Pharmaceutical Holding Co Ltd Insider Trading

  • The most recent transaction was 13,157 units bought on March 17, 2021 by John Childs worth over $1M
  • In the last 4 years, insiders at Biohaven Pharmaceutical Holding Co Ltd sold an estimated value of $183.28M and bought an estimated value of $36.57M
  • The most active traders are Gregory Bailey,  Kimberly Gentile, SVP,  and Robert Berman, Special Projects & Med Ovrsght
  • Insider trading is most common in May, with the busiest year in 2019

Biohaven Pharmaceutical Holding Co Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1